Insider Trading: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

46.21USD
23 Jul 2014
Price Change (% chg)

$0.79 (+1.74%)
Prev Close
$45.42
Open
$45.62
Day's High
$46.44
Day's Low
$45.41
Volume
527,399
Avg. Vol
783,514
52-wk High
$54.25
52-wk Low
$28.86

Search Stocks
BIBERSTEIN KATHRYN L
Trading Date Type Shares Traded Price Shares Held
29 Jun 2014 Buy 8,475 $12.30 69,783
29 Jun 2014 Sell 8,475 $50.26 69,783
16 Jun 2014 Buy 8,400 $12.30 69,783
16 Jun 2014 Sell 8,400 $47.41 69,783
27 May 2014 Sell 1,221 $45.74 69,783
27 May 2014 Buy 3,750 $0.00 69,783
20 May 2014 Sell 1,465 $44.48 67,254
20 May 2014 Buy 4,500 $0.00 67,254
19 May 2014 Buy 3,750 $0.00 67,254
19 May 2014 Sell 1,221 $43.98 67,254
16 May 2014 Sell 1,018 $43.59 61,690
16 May 2014 Buy 3,125 $0.00 61,690
18 Dec 2013 Buy 2,067 $14.90 59,583
18 Dec 2013 Buy 5,625 $12.30 59,583
17 Nov 2013 Buy 3,750 $0.00 51,891
17 Nov 2013 Sell 1,770 $36.89 51,891
25 May 2013 Sell 1,003 $32.84 49,911
25 May 2013 Buy 2,125 $0.00 49,911
20 May 2013 Buy 4,500 $0.00 48,789
20 May 2013 Sell 2,125 $31.98 48,789
19 May 2013 Sell 1,770 $31.04 46,414
19 May 2013 Buy 3,750 $0.00 46,414
16 May 2013 Buy 3,125 $0.00 46,414
16 May 2013 Sell 1,356 $31.69 46,414
16 Apr 2013 Buy 21,500 $12.16 42,665

Institutional Holders

% Shares Owned: 96.01%
# of Holders: 284
Total Shares Held: 138,747,458
3 Mo. Net Change: -128,623
# New Positions: 3
# Closed Positions: 1
# Increased Positions: 11
# Reduced Positions: 11
# Net Buyers: 0

Officers & Directors

Name Age Since Current Position

Richard Pops

52 2011 Chairman of the Board, Chief Executive Officer

Shane Cooke

51 2011 President

James Frates

47 2011 Chief Financial Officer, Senior Vice President

Gordon Pugh

55 2011 Chief Operating Officer, Senior Vice President, Chief Risk Officer

Kathryn Biberstein

54 2011 Senior Vice President, Chief Compliance Officer, General Counsel, Secretary

Rebecca Peterson

38 Senior Vice President

James Botkin

64 2011 Senior Vice President - Operations

Elliot Ehrich

54 2011 Senior Vice President - Research and Development, Chief Medical Officer

Michael Landine

59 2011 Senior Vice President - Corporate Development

Srdjan Stankovic

56 2013 Senior Vice President - Clinical Development

Mark Stejbach

50 2012 Senior Vice President, Chief Commercial Officer

Peter Norman

2013 Vice President - Government Affairs and Policy

Paul Mitchell

60 2012 Lead Independent Director

Nancy Wysenski

56 2013 Director

David Anstice

65 2011 Independent Director

Floyd Bloom

76 2011 Independent Director

Robert Breyer

69 2011 Independent Director

Wendy Dixon

58 2011 Independent Director

Geraldine Henwood

59 2011 Independent Director
Search Stocks